Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Simvastatin Inhibits Experimental Colon Cancer Growth
Link ID 8821
Title Simvastatin Inhibits Experimental Colon Cancer Growth
Url http://www.medscape.com/viewarticle/580708?src=rss
Description Korean investigators report that simvastatin inhibits colon cancer development by inducing apoptosis and suppressing angiogenesis in mice with experimentally induced tumors, in research conducted at Seoul National University College of Medicine. Reuters Health Information
Category Articles > Gastroenterology
Keywords
Date Sep 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Long-Term Hepatitis B Outlook Often Good
  The majority of Caucasian patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis become inactive carriers over time, Italian researchers report. Reuters Health Information
Category:   Articles > Gastroenterology


2. Review Article: Gastrointestinal Sensory and Motor Disturbances in Inflammatory Bowel Disease –
  The authors aimed to document the epidemiologic and clinical significance of functional alterations of gut motility and sensitivity in patients with IBD.
Alimentary Pharmacology & Therapeutics
Category:   Articles > Gastroenterology


3. Drug Insight: Antiangiogenic Therapies for Gastrointestinal Cancers--Focus on Monoclonal Antibodies
  This review considers antiangiogenic therapy for colorectal, gastric, hepatocellular and pancreatic cancer. The mechanism of action and application of bevacizumab are emphasized, but other potential antiangiogenic targets and therapies are also discussed.
Nature Clinical Practice Gastroenterology & Hepatology
Category:   Articles > Gastroenterology


4. "Vigilant" Monitoring Needed for Adverse Events With Cyclosporine for IBD
  Cyclosporine therapy for inflammatory bowel disease (IBD) is associated with a high frequency of minor and major adverse events, according to a retrospective study. Reuters Health Information
Category:   Articles > Gastroenterology


5. Botulinum Toxin A No Better Than Placebo for Delayed Gastric Emptying
  Intrapyloric injection of botulinum toxin A (BoNT/A) is not superior to placebo for the treatment of delayed gastric emptying, according to study findings published in the February issue of the American Journal of Gastroenterology. Reuters Health Information
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS